Atlas Trials

Bacterial Conjunctivitis

27 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bacterial Conjunctivitis

RecordFirmDate
Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers (NCT03235141)Beijing Tongren Hospital2017-07-07
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo (NCT03004924)Shire2017-03-29
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis (NCT02432807)Kurobe LLC2015-05-01
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis (NCT01877694)NovaBay Pharmaceuticals, Inc.2013-06-01
Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis (NCT01740388)Bausch & Lomb Incorporated2013-02-01
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients (NCT01573910)Alcon Research2012-05-01
Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis (NCT01330355)Bausch & Lomb Incorporated2011-05-01
Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis (NCT01227863)Azidus Brasil2011-02-01
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis (NCT01238783)Alcon Research2011-01-01
Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle (NCT01175590)Bausch & Lomb Incorporated2010-06-01
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis (NCT00972777)Bausch & Lomb Incorporated2009-10-01
Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis (NCT00759148)Alcon Research2008-10-01
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment (NCT00798577)Alcon Research2008-10-01
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis (NCT00518089)Allergan2008-02-01
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis (NCT00509873)Allergan2007-08-01
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis (NCT00464438)Allergan2007-06-01
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora (NCT00312338)Alcon Research2006-06-01
AL-15469A for the Treatment of Bacterial Conjunctivitis (NCT00332293)Alcon Research2006-05-01
AL-15469A for the Treatment of Bacterial Conjunctivitis (NCT00331916)Alcon Research2005-11-01
Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis (NCT00622908)Bausch & Lomb Incorporated2004-12-01
Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis (NCT00565123)Laser Microsurgery Centre, Poland2004-09-01
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) (NCT00105534)Merck Sharp & Dohme LLC2004-07-01
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) (NCT00105469)Merck Sharp & Dohme LLC2004-07-01

Track Bacterial Conjunctivitis automatically

Every clearance here is in the API, with alerts when new ones post.